XERS: Xeris Biopharma Holdings Inc. Stocks News on April 19, 2025

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

XERS

GlobeNewswire

2 days ago

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

Xeris Announces Changes to Its Board of Directors

XERS

Business Wire

22 days ago

Xeris Announces Changes to Its Board of Directors

XERS

Insider Monkey

23 days ago

Is Xeris Biopharma Holdings (XERS) The Hot Biotech Stock Under $5?

XERS

Zacks

a month ago

Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?

XERS

Insider Monkey

a month ago

Xeris Biopharma Holdings (XERS): Among the Best Stocks to Invest in for a Stock Market Game

XERS

Simply Wall St.

a month ago

Calculating The Fair Value Of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)

XERS

MT Newswires

a month ago

Xeris Biopharma Says US FDA Approves Gvoke VialDx for Diagnostic Use

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

XERS

Business Wire

a month ago

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid

XERS

GuruFocus.com

a month ago

Xeris Biopharma Holdings Inc (XERS) Q4 2024 Earnings Call Highlights: Surpassing Revenue ...

XERS

Zacks

a month ago

Here's What Key Metrics Tell Us About Xeris Biopharma (XERS) Q4 Earnings

XERS

Zacks

a month ago

Xeris Biopharma (XERS) Reports Q4 Loss, Misses Revenue Estimates

XERS

Associated Press Finance

a month ago

Xeris Biopharma: Q4 Earnings Snapshot

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

XERS

Business Wire

a month ago

Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance

Verrica Pharmaceuticals Inc. (VRCA) Expected to Beat Earnings Estimates: Should You Buy?

XERS

Zacks

2 months ago

Verrica Pharmaceuticals Inc. (VRCA) Expected to Beat Earnings Estimates: Should You Buy?

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

XERS

Business Wire

2 months ago

Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025

XERS

Zacks

2 months ago

Xeris Biopharma (XERS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

XERS

Business Wire

2 months ago

Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer

XERS

Simply Wall St.

2 months ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 50% stake, while 45% is held by institutions

Xeris to Participate in Upcoming Investor Conferences

XERS

Business Wire

2 months ago

Xeris to Participate in Upcoming Investor Conferences

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

XERS

PR Newswire

3 months ago

The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness

Xeris Biopharma raises FY24 revenue view to $203M from $198M-$202M

XERS

TipRanks

3 months ago

Xeris Biopharma raises FY24 revenue view to $203M from $198M-$202M

XERS

MT Newswires

3 months ago

Xeris Biopharma Lifts 2024 Revenue Guidance

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

XERS

Business Wire

3 months ago

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

XERS

Business Wire

3 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

XERS

Business Wire

5 months ago

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

XERS

Simply Wall St.

5 months ago

Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long

XERS

MT Newswires

5 months ago

Piper Sandler Downgrades Xeris Biopharma to Neutral From Overweight, $3 Price Target

XERS

GuruFocus.com

5 months ago

Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

XERS

Zacks

5 months ago

Xeris Biopharma (XERS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

XERS

Zacks

5 months ago

Xeris Biopharma (XERS) Reports Q3 Loss, Tops Revenue Estimates

XERS

Associated Press Finance

5 months ago

Xeris Biopharma: Q3 Earnings Snapshot

Xeris Biopharma Reports Third Quarter 2024 Financial Results

XERS

Business Wire

5 months ago

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

XERS

Business Wire

6 months ago

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News

XERS

Simply Wall St.

6 months ago

Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News

XERS

Business Wire

7 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Zevra Therapeutics (ZVRA) Moves 9.1% Higher: Will This Strength Last?

XERS

Zacks

7 months ago

Zevra Therapeutics (ZVRA) Moves 9.1% Higher: Will This Strength Last?

XERS

Simply Wall St.

7 months ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) most popular amongst individual investors who own 53% of the shares, institutions hold 43%

XERS

Business Wire

8 months ago

Xeris to Participate in Upcoming Investor Conferences

XERS

Zacks

8 months ago

Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates

XERS

Associated Press Finance

8 months ago

Xeris Biopharma: Q2 Earnings Snapshot

Xeris Biopharma Reports Second Quarter 2024 Financial Results

XERS

Business Wire

8 months ago

Xeris Biopharma Reports Second Quarter 2024 Financial Results

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline

XERS

Zacks

9 months ago

Earnings Preview: Amneal Pharmaceuticals (AMRX) Q2 Earnings Expected to Decline

XERS

Zacks

9 months ago

Will Xeris Biopharma (XERS) Report Negative Earnings Next Week? What You Should Know

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

XERS

Business Wire

9 months ago

Xeris Biopharma to Report Second Quarter 2024 Financial Results on August 8, 2024

XERS

Zacks

9 months ago

Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?

XERS

MT Newswires

9 months ago

Xeris Biopharma Appoints John Shannon as CEO

Xeris Biopharma Announces CEO Succession Plan

XERS

Business Wire

9 months ago

Xeris Biopharma Announces CEO Succession Plan

XERS

Business Wire

10 months ago

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

XERS

Simply Wall St.

10 months ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Shift From Loss To Profit

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

XERS

Business Wire

a year ago

Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024

XERS

MT Newswires

a year ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

XERS

MT Newswires

a year ago

Xeris Biopharma Says Potential Levothyroxine Injection Preferred Over Oral Formulation; Shares Rise

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

XERS

Business Wire

a year ago

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

Xeris to Participate in the Jefferies Global Healthcare Conference

XERS

Business Wire

a year ago

Xeris to Participate in the Jefferies Global Healthcare Conference

XERS

GuruFocus.com

a year ago

Xeris Biopharma Holdings Inc (XERS) Q1 2024 Earnings: Revenue Growth Amidst Challenges

XERS

Insider Monkey

a year ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations

XERS

Simply Wall St.

a year ago

Xeris Biopharma Holdings First Quarter 2024 Earnings: Misses Expectations

XERS

Thomson Reuters StreetEvents

a year ago

Q1 2024 Xeris Biopharma Holdings Inc Earnings Call

XERS

Zacks

a year ago

Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates

XERS

Associated Press Finance

a year ago

Xeris Biopharma: Q1 Earnings Snapshot

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

XERS

Business Wire

a year ago

Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events

XERS

MT Newswires

a year ago

Xeris Biopharma Collaborating With Beta Bionics for Development, Commercialization of Glucagon Product

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics

XERS

ACCESSWIRE

a year ago

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics

Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock

XERS

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

XERS

Business Wire

a year ago

Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?

XERS

Zacks

a year ago

Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?

XERS

Simply Wall St.

a year ago

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

XERS

Business Wire

a year ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

XERS

Business Wire

a year ago

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

XERS

Simply Wall St.

a year ago

Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results

XERS

GuruFocus.com

a year ago

Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023

XERS

Insider Monkey

a year ago

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript

XERS

Thomson Reuters StreetEvents

a year ago

Q4 2023 Xeris Biopharma Holdings Inc Earnings Call

XERS

Zacks

a year ago

Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates

XERS

Associated Press Finance

a year ago

Xeris Biopharma: Q4 Earnings Snapshot

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

XERS

Business Wire

a year ago

Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

XERS

Business Wire

a year ago

Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital

XERS

Zacks

a year ago

Why Xeris (XERS) Might Surprise This Earnings Season

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

XERS

Business Wire

a year ago

Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

XERS

Business Wire

a year ago

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

XERS

GlobeNewswire

a year ago

PIMCO Closed-End Funds Declare Monthly Common Share Distributions

Ahead of Groundhog Day, LendingTree Introduces Spring: A Fresh New App Where Smart Money Habits Take Root

XERS

PR Newswire

a year ago

Ahead of Groundhog Day, LendingTree Introduces Spring: A Fresh New App Where Smart Money Habits Take Root

Logility Advances Supply Chain Supplier Management Capabilities for Apparel and Soft Goods Companies

XERS

Business Wire

a year ago

Logility Advances Supply Chain Supplier Management Capabilities for Apparel and Soft Goods Companies

XERS

Investing.com

a year ago

Dollar edges higher ahead of Fed meeting, payrolls

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?

XERS

Zacks

a year ago

Domo (DOMO) Soars 9.0%: Is Further Upside Left in the Stock?

Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14

XERS

GlobeNewswire

a year ago

Udemy to Announce Fourth Quarter and Full Year 2023 Results on February 14

XERS

Thomson Reuters StreetEvents

a year ago

Q4 2023 CrossFirst Bankshares Inc Earnings Call

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

XERS

Zacks

a year ago

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Matterport to Announce Fourth Quarter & Full Year 2023 Results on February 20, 2024

XERS

GlobeNewswire

a year ago

Matterport to Announce Fourth Quarter & Full Year 2023 Results on February 20, 2024

Compared to Estimates, CrossFirst (CFB) Q4 Earnings: A Look at Key Metrics

XERS

Zacks

a year ago

Compared to Estimates, CrossFirst (CFB) Q4 Earnings: A Look at Key Metrics

Anterix (ATEX) Loses -13.76% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

XERS

Zacks

a year ago

Anterix (ATEX) Loses -13.76% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

XERS

Zacks

a year ago

Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza

The RMR Group Announces Quarterly Dividend on Common Shares

XERS

Business Wire

a year ago

The RMR Group Announces Quarterly Dividend on Common Shares

Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab

XERS

Business Wire

a year ago

Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts

XERS

PR Newswire

a year ago

i-80 Provides 2023 Summary & 2024 Plans - Highlighting Numerous Achievements & Catalysts

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

XERS

InvestorPlace

a year ago

7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024

Institutional owners may ignore Evolv Technologies Holdings, Inc.'s (NASDAQ:EVLV) recent US$65m market cap decline as longer-term profits stay in the green

XERS

Simply Wall St.

a year ago

Institutional owners may ignore Evolv Technologies Holdings, Inc.'s (NASDAQ:EVLV) recent US$65m market cap decline as longer-term profits stay in the green

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

XERS

GlobeNewswire

a year ago

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

XERS

Business Wire

a year ago

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

XERS

GlobeNewswire

a year ago

Latest Xeris Biopharma Holdings Inc. (XERS) News on April 19, 2025

Share on Social Networks: